MAUREEN NDU: Open Payments
NPI 1447725395 · ELIZABETH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 26 payments from 8 companies in 2025. Trend: 2023 $1,204 · 2024 $1,368 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 11 | $366 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $196 |
| ABBVIE INC. | 5 | $171 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 2 | $100 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Luye Pharma (USA) Ltd. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: LYBALVI, CAPLYTA, VRAYLAR, ARISTADA, INGREZZA, UZEDY, COBENFY, ERZOFRI EXTENDED-RELEASE.
Industry payments across NJ — which companies pay providers there.
